ClearSign appoints G. Todd Silva to board of directors effective August 1, 2024

ClearSign Technologies Corp

Mr. Silva, nominated by clirSPV LLC, fills vacancy created by Robert T. Hoffman, Sr.'s June 2024 resignation.
He brings over 30 years of leadership and finance experience; currently CFO of Radiance Therapeutics.
Mr. Silva will receive quarterly RSU grants of $15,000 under the 2021 Equity Incentive Plan.
Initial RSU grant pro-rated for the portion of Q3 2024 served on the board.
Appointment effective August 1, 2024; no other arrangements or family relationships disclosed.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

G. Todd Silva

Director

CLIR · ClearSign Technologies Corp

Effective: 2024-08-01
Filed: August 6, 2024, 7:59 PM ET

Upon recommendation of the Governance Committee, and effective as of August 1, 2024 (the “Effective Date”), Mr. Silva was appointed to the Board as the SPV’s designee to fill the vacancy created by Mr. Hoffman’s resignation.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

G. Todd Silva was appointed as Director at ClearSign Technologies Corp.

Action: appointed
Role: Director

Exact text from the filing

Upon recommendation of the Governance Committee, and effective as of August 1, 2024 (the “Effective Date”), Mr. Silva was appointed to the Board as the SPV’s designee to fill the vacancy created by Mr. Hoffman’s resignation.

View on SEC.gov

ClearSign Technologies Corp filing history →

Source: SEC EDGAR

accession 0001104659-24-086124

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.